On June 18, 2024, Stoke Therapeutics, Inc. and Huw Nash, Ph.D., the Company's Chief Operating Officer and Chief Business Officer, announced that they have mutually agreed that Dr. Nash would step down from his position as Chief Operating Officer, effective immediately. Dr. Nash will continue to serve and perform his duties as Chief Business Officer.